Hard USMLE Oncology Practice Questions

One in three individuals will develop cancer during their lifetime, making oncology a cornerstone of medical board examinations. Succeeding on the Step exams requires a deep understanding of molecular pathways, paraneoplastic syndromes, and targeted pharmacotherapy. These Hard USMLE Oncology Practice Questions are designed to challenge your clinical reasoning and prepare you for the highest-weighted topics in cancer biology.

Concept Explanation

Oncology in the context of the USMLE focuses on the pathophysiology of malignant transformation and the specific clinical manifestations of various tumors. At its core, oncology is the study of dysregulated cell growth caused by genetic mutations in proto-oncogenes and tumor suppressor genes. To excel in this subject, you must distinguish between various pathological presentations and understand how specific mutations, such as those in the TP53 or KRAS genes, dictate both the presentation and the treatment of the disease. Furthermore, the boards frequently test the intersection of oncology with other systems, such as the hematologic malignancies and paraneoplastic effects on the endocrine and renal systems. Understanding the mechanism of action of chemotherapy—ranging from alkylating agents to modern tyrosine kinase inhibitors—is essential for answering multi-step management questions.

Solved Examples

1. Case Study: Lung Mass and Electrolyte Imbalance
   A 65-year-old male with a 50-pack-year smoking history presents with a cough and a 15-lb weight loss. Laboratory studies show a serum sodium of 122 mEq/L. A chest X-ray reveals a central hilar mass. What is the most likely diagnosis and the associated paraneoplastic syndrome?
   
   1. Identify the clinical clues: Smoking history, central lung mass, and hyponatremia.
   2. Correlate the location: Central masses are typically Small Cell Lung Cancer (SCLC) or Squamous Cell Carcinoma.
   3. Analyze the electrolyte: Hyponatremia in a lung cancer patient often indicates the Syndrome of Inappropriate Antidiuretic Hormone (SIADH).
   4. Conclusion: Small Cell Lung Carcinoma producing ectopic ADH.
2. Case Study: Pediatric Abdominal Mass
   A 3-year-old girl is brought in for a palpable abdominal mass that does not cross the midline. She has no other symptoms. Hematuria is noted on urinalysis. What is the most likely gene mutation involved?
   
   1. Analyze the age and location: A unilateral abdominal mass in a child is highly suggestive of Wilms tumor (nephroblastoma).
   2. Differentiate: Unlike neuroblastoma, Wilms tumor usually does not cross the midline and involves the renal parenchyma.
   3. Identify the genetics: Wilms tumor is associated with the WT1 or WT2 genes on chromosome 11.
   4. Conclusion: Loss-of-function mutation in the WT1 gene.
3. Case Study: Breast Cancer Genetics
   A 34-year-old woman with a family history of early-onset breast cancer tests positive for a BRCA1 mutation. What is the primary function of the protein encoded by this gene?
   
   1. Recall the gene type: BRCA1 is a tumor suppressor gene.
   2. Identify the molecular role: It is involved in the repair of double-stranded DNA breaks.
   3. Determine the mechanism: It utilizes homologous recombination to maintain genomic stability.
   4. Conclusion: DNA repair via homologous recombination.

Practice Questions

1. A 58-year-old male with a history of chronic hepatitis C presents with right upper quadrant pain and weight loss. Imaging shows a large mass in the liver. Laboratory findings reveal an elevated alpha-fetoprotein (AFP). Histological examination shows polygonal cells with prominent nucleoli and bile globules in the cytoplasm. Which of the following is the most significant risk factor for this patient's condition in the United States?
2. A 45-year-old female presents with a painless lump in her neck. Fine-needle aspiration reveals cells with large, overlapping nuclei containing finely dispersed chromatin and prominent endonuclear grooves. Psammoma bodies are also noted. What is the most likely histological diagnosis?
3. A 70-year-old man presents with bone pain and fatigue. A skeletal survey shows multiple "punched-out" lytic lesions in the skull and ribs. Serum protein electrophoresis (SPEP) shows an M-spike. Which cytokine is primarily responsible for the activation of osteoclasts in this disease?

4. A 22-year-old male presents with a rapidly enlarging mass in his jaw. A biopsy of the mass shows a "starry sky" appearance with numerous tingible body macrophages. Genetic analysis reveals a translocation between chromosomes 8 and 14. Which of the following proteins is overexpressed in this patient?
5. A patient undergoing chemotherapy for an aggressive lymphoma develops sudden onset of oliguria, cardiac arrhythmias, and muscle cramps. Laboratory results reveal hyperkalemia, hyperphosphatemia, and hyperuricemia. What is the most appropriate initial preventive treatment for this condition?
6. A 62-year-old woman with a history of smoking presents with painless hematuria. Cystoscopy reveals a papillary tumor in the bladder. Exposure to which of the following substances is a known risk factor for this malignancy?
7. A 55-year-old man with a history of GERD presents with progressive dysphagia to solids. Endoscopy reveals a mass in the lower third of the esophagus. Biopsy confirms adenocarcinoma. This malignancy most likely arose from which of the following precursor conditions?
8. A 40-year-old male presents with episodic flushing, wheezing, and diarrhea. A 24-hour urine collection shows elevated 5-hydroxyindoleacetic acid (5-HIAA). Where is the most common primary site for this tumor?
9. A 19-year-old male presents with a firm, painless testicular mass. Laboratory studies show elevated beta-hCG but normal AFP. Pathological examination shows large cells with clear cytoplasm and central nuclei ("fried egg" appearance). What is the diagnosis?
10. A 60-year-old male with chronic myeloid leukemia (CML) is started on a medication that inhibits the BCR-ABL tyrosine kinase. Which of the following drugs was likely prescribed?

Answers & Explanations

1. Hepatocellular Carcinoma: The most significant risk factor for HCC in the United States is cirrhosis, often secondary to Hepatitis C or alcoholic liver disease. The presence of bile globules and elevated AFP are hallmark features.
2. Papillary Thyroid Carcinoma: The description of "Orphan Annie eye" nuclei (finely dispersed chromatin) and psammoma bodies is pathognomonic for papillary thyroid cancer, the most common thyroid malignancy.
3. IL-1 (Osteoclast Activating Factor): In Multiple Myeloma, neoplastic plasma cells produce cytokines like IL-1 and TNF, which stimulate RANK-L expression, leading to osteoclast activation and lytic bone lesions.
4. c-myc: The $t(8;14)$ translocation moves the c-myc proto-oncogene next to the immunoglobulin heavy chain locus, leading to its constitutive expression and rapid cell proliferation in Burkitt lymphoma.
5. Aggressive Hydration and Allopurinol/Rasburicase: This patient has Tumor Lysis Syndrome. Prevention involves vigorous intravenous hydration and inhibiting uric acid production with allopurinol or breaking it down with rasburicase.
6. Aniline Dyes/Smoking: Transitional cell carcinoma of the bladder is strongly linked to cigarette smoking and occupational exposure to aniline dyes used in the rubber and textile industries.
7. Barrett Esophagus: Adenocarcinoma of the esophagus typically occurs in the distal third and arises from intestinal metaplasia (Barrett's) caused by chronic acid reflux.
8. Small Intestine (Ileum): Carcinoid syndrome occurs when a neuroendocrine tumor (most commonly in the ileum) metastasizes to the liver, bypassing first-pass metabolism and releasing serotonin into the systemic circulation.
9. Seminoma: This is the most common germ cell tumor in young men. It presents with a "fried egg" appearance and can occasionally produce beta-hCG, but never AFP.
10. Imatinib: This is a targeted small-molecule inhibitor of the BCR-ABL tyrosine kinase, which is the product of the Philadelphia chromosome $t(9;22)$ found in CML.

1. Which paraneoplastic syndrome is most commonly associated with Squamous Cell Carcinoma of the lung?

• ASIADH
• BCushing Syndrome
• CHypercalcemia
• DLambert-Eaton Syndrome

Frequently Asked Questions

What is the difference between a proto-oncogene and a tumor suppressor gene?

Proto-oncogenes are normal genes that promote cell growth, while tumor suppressor genes act as the "brakes" to inhibit cell division or repair DNA. A gain-of-function mutation in a proto-oncogene creates an oncogene, whereas a loss-of-function mutation in both alleles of a tumor suppressor gene leads to cancer.

How does the USMLE test paraneoplastic syndromes?

The exam typically presents a patient with a known or suspected malignancy and then introduces an unrelated systemic symptom, such as muscle weakness or electrolyte abnormalities. You must link the specific tumor type, like Small Cell Lung Cancer, to its secreted product, such as ACTH or ADH.

Why is the Philadelphia chromosome significant?

The Philadelphia chromosome, a translocation between chromosomes 9 and 22, creates the BCR-ABL fusion gene. This gene encodes a constitutively active tyrosine kinase that drives the pathogenesis of Chronic Myeloid Leukemia and serves as a direct target for therapy.

What are the hallmarks of Lynch Syndrome?

Lynch Syndrome, or Hereditary Nonpolyposis Colorectal Cancer (HNPCC), is caused by mutations in DNA mismatch repair genes like MSH2 or MLH1. It leads to microsatellite instability and an increased risk of colorectal, endometrial, and ovarian cancers.

How can I distinguish between Hodgkin and Non-Hodgkin Lymphoma?

Hodgkin Lymphoma is characterized by the presence of Reed-Sternberg cells (large cells with "owl-eye" nuclei) and typically spreads in a contiguous fashion. Non-Hodgkin Lymphoma involves a diverse group of B-cell or T-cell malignancies that often present with non-contiguous lymphadenopathy and extranodal involvement.